• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

At epicenter of Zika outbreak, dengue immunity provided protection

Bioengineer by Bioengineer
February 7, 2019
in Immunology
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New Haven, Conn. — When the Zika virus arrived in the Americas in early 2015, it struck hard, infecting 73% of people in one Brazilian community at the epicenter of the pandemic, according to a new study led by the Yale School of Public Health.

The study, conducted in collaboration with the Oswaldo Cruz Foundation-Brazilian Ministry of Health and international partners, is published in Science.

The findings confirm why the epidemic of Zika-associated birth defects was so severe in Brazil. “The exceedingly high infection rate among pregnant women from impoverished communities such as our study site was surely the major reason why we had a large outbreak of microcephaly among infants at the end of 2015,” said Albert Ko, a professor at the Yale School of Public Health and one of the study’s lead authors.

The research also reveals that people who had antibodies to dengue — another common mosquito-borne virus circulating in much of the world’s tropical regions — were less likely to become infected with Zika during the outbreak.

Zika and dengue viruses share many genetic similarities and circulate in the same regions. A key open question has been whether antibodies that are generated from a dengue infection protect people or make them more susceptible to a Zika infection.

“This study is the first to evaluate this question and demonstrate that immunity to dengue can protect against a Zika infection in human populations,” said Federico Costa, associate professor at the Federal University of Bahia and associate adjunct professor at the Yale School of Public Health.

The researchers followed 1,453 residents from a densely populated slum community in the city of Salvador, Brazil, during the 2015 Zika outbreak. They used a novel test for identifying Zika infections in surveys of large populations.

While the overall rate of infection was high in the neighborhood that was studied, the researchers found wide differences in the risk of Zika infection across short distances. Depending on where people lived, rates of infection varied from a low of 29% to a high of 83%.

The authors state that although there were pockets of the community that were not hit by Zika during the outbreak, the large majority of the population was infected with the highly transmissible virus and developed immunity to this virus, which in turn drove transmission to extinction and caused the outbreak to burn out.

“The Zika pandemic has created overall high rates of immunity to this virus in the Americas, which will be a barrier for outbreaks in coming years,” said Isabel Rodriguez-Barraquer, an assistant professor at University of California, San Francisco.

###

The study was supported by the Yale School of Public Health, Brazilian Ministries of Health, Education and Science and Technology, and the National Institutes of Health.

Media Contact
Michael Greenwood
[email protected]
203-737-5151

Tags: Developing CountriesDisease in the Developing WorldEpidemiologyInfectious/Emerging DiseasesMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    54 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancing Microbial Risk Assessment Through Detection Technology Evolution

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.